Category: us corporate news

us corporate news

Biglari Holdings Inc. 2025 Annual Report: Business Overview, Risk Factors, and Financial Statements

Minichart

March 2, 2026

Biglari Holdings Inc. 2025 Annual Report: Key Investor Takea...

Continue Reading 0

us corporate news

Sarepta Therapeutics, Inc. 2025 Annual Report: SEC Form 10-K Filing, Financials, Risk Factors, and Business Overview

Minichart

March 2, 2026

Sarepta Therapeutics, Inc. Annual Report 2025: Key Highlight...

Continue Reading 0

us corporate news

GT Biopharma, Inc. 2025 Annual Report: TriKE® Immuno-Oncology Pipeline, Risks, Patents, and Business Overview

Minichart

March 2, 2026

GT Biopharma, Inc. 2025 Annual Report: Key Highlights and In...

Continue Reading 0

us corporate news

Geron Corporation 2025 Annual Report: RYTELO Commercialization, Risks, and Business Overview

Minichart

March 2, 2026

Company Overview Geron Corporation (Nasdaq: GERN) is now ...

Continue Reading 0

us corporate news

Steven Madden, Ltd. 2025 Annual Report: Business Overview, Brands, Segments, Risks, and Corporate Strategy 3436374148

Minichart

March 2, 2026

Steven Madden, Ltd. 2025 Annual Report Analysis: Key Investo...

Continue Reading 0

us corporate news

Sionna Therapeutics 2025 Annual Report: Clinical Pipeline, Risk Factors, Intellectual Property, and Business Overview

Minichart

March 2, 2026

Sionna Therapeutics, Inc. 2025 Annual Report: Key Financial ...

Continue Reading 0

us corporate news

Dyne Therapeutics, Inc. 2025 Annual Report: Business Overview, FORCE Platform Advantages, and Strategic Pipeline Expansion

Minichart

March 2, 2026

Dyne Therapeutics 2025 Annual Report: Investor Analysis ...

Continue Reading 0

us corporate news

Apogee Therapeutics 2025 Annual Report: Pipeline Overview, Strategy, and Clinical Progress in Inflammatory and Immunology Markets

Minichart

March 2, 2026

Key Highlights from Apogee Therapeutics, Inc. 2025 Annual Re...

Continue Reading 0

us corporate news

uniQure N.V. 2025 Annual Report: Gene Therapy Pipeline, Clinical Progress, Risks, and Financial Overview

Minichart

March 2, 2026

uniQure N.V. 2025 Annual Report: Key Highlights for Investor...

Continue Reading 0

us corporate news

Millrose Properties, Inc. 2025 Annual Report: Business Overview, Risk Factors, and Glossary of Defined Terms

Minichart

March 2, 2026

Millrose Properties, Inc. 2025 Annual Report – Key Investor ...

Continue Reading 0

Category: us corporate news

Join Our Investing Seminar